Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPAP Effect on Polycythemia in OSA
NCT06089603Phase 4Recruiting
- Sponsor
- Ramón y Cajal University Hospital
- Start
- Nov 2023
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Ramón y Cajal University Hospital. Primary endpoint: Change from baseline of hematocrit at 12 months. Started Nov 2023; status: recruiting.
Beyond the preview
Go deeper on NCT06089603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06089603.